Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
115,145
result(s) for
"Causes of"
Sort by:
The end of illness
\"From one of the world's foremost physicians and researchers, a monumental work that radically redefines our conventional conceptions of health and illness to offer new methods for living a long, healthy life. After considering the discoveries that have led to progress in treating some diseases, Dr. David B. Agus asked an essential question: Why aren't we better at curing illnesses like cancer? Based on his groundbreaking research and the clinical trials he has conducted at the nation's leading medical centers, he came to the realization that we've been approaching medicine from a faulty perspective, and the best way to prevent and combat maladies like cancer, heart disease, autoimmune disorders, and neurodegeneration is to first embrace a totally new view of the human body. What Is Health? asks readers to reconsider everything they think they know about health--and give up believing many myths that may actually be causing them harm and decreasing longevity. These myths revolve around a spectrum of misconceptions, from the benefits of vitamins and supplements to the role of DNA in one's fate. In attempting to reduce our understanding of ailments to a mutation, germ, or deficiency, Dr. Agus proves we have forgotten that the body is a complex system. He presents a systemic picture of the body's vast mechanisms that drive it either toward or away from sickness, empowering readers to take charge of their individual health in very personal, customized ways they've never imagined before. Along the way, Dr. Agus offers insights and access to breathtaking and powerful new technologies that promise to transform medicine in our generation. He also shows that there is no \"right\" answer in health decisions. This is a radically different approach that will not only change how we care for ourselves, but also how we develop the next generation of treatments and cures. What Is Health? represents a dramatic departure from orthodox thinking that promises to revolutionize our quest for long, healthy lives\"-- Provided by publisher.
Book
Body odor disgust sensitivity
Odors are important disease cues, and disgust sensitivity to body odors reflects individual differences in disease avoidance. The body odor disgust sensitivity (BODS) scale provides a rapid and valid assessment of individual differences. Nevertheless, little is known about how individual differences in BODS might correlate with overall odor perception or how it is related to other differences in emotional reactivity (e.g., affect intensity). We investigated how BODS relates to perceptual ratings of pleasant and unpleasant odors. We aggregated data from 4 experiments (total N = 190) that were conducted in our laboratory, and where valence and intensity ratings were collected. Unpleasant odors were body-like (e.g., sweat-like valeric acid), which may provide disease cues. The pleasant odors were, in contrast, often found in soap and cleaning products (e.g., lilac, lemon). Across experiments, we show that individuals with higher BODS levels perceived smells as more highly valenced overall: unpleasant smells were rated as more unpleasant, and pleasant smells were rated as more pleasant. These results suggest that body odor disgust sensitivity is associated with a broader pattern of affect intensity which causes stronger emotional responses to both negative and positive odors. In contrast, BODS levels were not associated with odor intensity perception. Furthermore, disgust sensitivity to odors coming from external sources (e.g., someone else's sweat) was the best predictor of odor valence ratings. The effects were modest in size. The results validate the BODS scale as it is explicitly associated with experimental ratings of odor valence.
Journal Article
Medical mysteries : science researches conditions from bizarre to deadly
Follow doctors and scientists as they attempt to discover the causes and cures for such rare diseases as Progeria, Morgellons Disease, Creutzfeldt-Jacobs Disease, and more.
Book
Generalized Eruptive Keratoacanthoma COVID-19 Vaccination Successfully Treated with Cemiplimab
In December 2020, a major vaccination program against COVID-19 commenced in Europe with vaccines such as Pfizer’s mRNABNT162b2 (Comirnaty[sup.®] ). Subsequent reports of immediate and delayed skin reactions emerged. This study presents a case of a 64-year-old male who developed multiple keratoacanthomas approximately two weeks after receiving a second booster dose of the Pfizer vaccine. The patient, who had significant medical history of hypertension and diabetes, presented with erythematous, crateriform lesions on his limbs. A physical examination and histopathological analysis confirmed the diagnosis of Generalized Eruptive Keratoacanthoma (GEKA). Treatment involved cemiplimab I.v. 350 mg administered every three weeks. Within two months, the patient showed significant improvement, with the disappearance of all lesions. Dermoscopy and histopathological exams supported the GEKA diagnosis, which is a rare variant of multiple keratoacanthomas. This case suggests a potential immune-mediated mechanism triggered by the COVID-19 vaccine, leading to the rapid development of keratoacanthomas. Treatment with cemiplimab showed promise, highlighting the potential of immune checkpoint inhibitors in managing multiple keratoacanthomas. Further research is needed to explore the efficacy and safety of such treatments.
Journal Article
The Origins of Major War
One of the most important questions of human existence is what drives nations to war-especially massive, system-threatening war. Much military history focuses on the who, when, and where of war. In this riveting book, Dale C. Copeland brings attention to bear on why governments make decisions that lead to, sustain, and intensify conflicts.
Copeland presents detailed historical narratives of several twentieth-century cases, including World War I, World War II, and the Cold War. He highlights instigating factors that transcend individual personalities, styles of government, geography, and historical context to reveal remarkable consistency across several major wars usually considered dissimilar. The result is a series of challenges to established interpretive positions and provocative new readings of the causes of conflict.
Classical realists and neorealists claim that dominant powers initiate war. Hegemonic stability realists believe that wars are most often started by rising states. Copeland offers an approach stronger in explanatory power and predictive capacity than these three brands of realism: he examines not only the power resources but the shifting power differentials of states. He specifies more precisely the conditions under which state decline leads to conflict, drawing empirical support from the critical cases of the twentieth century as well as major wars spanning from ancient Greece to the Napoleonic Wars.
eBook
